Figure 7From: Thiazolidinediones inhibit airway smooth muscle release of the chemokine CXCL10: in vitro comparison with current asthma therapiesThe effects of ciglitazone and fluticasone on asthmatic (A) and non-asthmatic (NA) ASMC CXCL10 release induced by cytomix. Confluent serum-deprived ASMC were treated with ciglitazone and fluticasone or vehicle 1 h prior to and during stimulation with cytomix and CXCL10 release after 24 h quantified using ELISA.Back to article page